Crescent Biopharma, Inc. (CBIO)

NASDAQ: CBIO · Real-Time Price · USD

11.60

-0.14 (-1.19%)

At close: Feb 20, 2026, 4:00 PM EST

11.65

+0.05 (0.43%)

After-hours: Feb 20, 2026, 7:48 PM EST

Crescent Biopharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024
Period Ending	Feb '26 Feb 20, 2026	Dec '24 Dec 31, 2024
Debt / Equity Ratio	-3.26	-3.26
Net Debt / Equity Ratio	-0.24	-0.24
Quick Ratio	3.62	3.62
Current Ratio	3.62	3.62
Return on Capital Employed (ROCE)	-264.40%	-264.40%

Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q